Gunderson Dettmer advised Natera, Inc. in a Rule 144A offering of over $285 million aggregate principal amount of convertible senior notes due. Public Offerings/Public Companies Partners Jeffrey R. Vetter and Jeffrey C. Thacker, corporate partner John Dietz and associates Ryan J. Gunderson, Leanne A. Gould and Matthew K. Rietfors led the team advising Natera.

The initial purchasers of the notes included JP Morgan, Morgan Stanley and Cowen & Company.

Natera, which trades on the Nasdaq under the ticker symbol “NTRA,” is a genetic testing company that specializes in analyzing microscopic quantities of DNA for reproductive health indications to provide preconception and prenatal genetic testing services primarily to OBGYN physicians and in vitro fertilization centers.